Clinical Study on Responder Prediction in Cardiac Resynchronization Therapy Using Individual Molecular Measurement of Natriuretic Peptide

Clinical Study on Responder Prediction in Cardiac Resynchronization Therapy Using Individual Molecular Measurement of Natriuretic Peptide - Clinical Study on Responder Prediction in Cardiac Resynchronization Therapy Using Individual Molecular Measurement of Natriuretic Peptide

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034148

Enrollment

100

Registered

2018-09-14

Start date

2013-08-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with cardiac resynchronization therapy (CRT)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients planning to implant CRT at our hospital and have serum creatinine level less than 1.5 mg/dl

Exclusion criteria

Exclusion criteria: Patients with serum creatinine level equal or over 1.5 mg/dl, dialysis, and who judged to be ineligible for participation

Design outcomes

Primary

Measure	Time frame
Deaths from any cause and heart failure admissions	—

Countries

Japan

Contacts

Public ContactKengo Kusano

National Cerebral and Cardiovascular Center Department of Cardiovascular Medicine

kusanokengo@ncvc.go.jp06-6833-5012

Outcome results